Publication:

Predictors of CD4+ lymphocyte count among HIV-Seropositive and HIV-Seronegative pregnant women in Dar Es Salaam, Tanzania

Loading...
Thumbnail Image

Date

2009

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

Kenya Medical Association
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Kapiga, SH, D Mwakagile, D Spiegelman, GI Msamanga, D Hunter, and WW Fawzi. 2009. “Predictors of CD4+ Lymphocyte Count among HIV-Seropositive and HIV-Seronegative Pregnant Women in Dar Es Salaam, Tanzania.” East African Medical Journal 77 (4). https://doi.org/10.4314/eamj.v77i4.46622.

Abstract

Objective: To determine the predictors of CD4+ lymphocyte count among pregnant women in Dar es Salaam, Tanzania,Methods: Between 04/1995 and 03/1997, HIV-seropositive (n=1,027) and HIV- seronegative (n=280) pregnant women were interviewed to obtain socio-demographic characteristics, Later, blood samples was collected for determination of T- lymphocyte subsets and other haematological indices. Results: CD4+ lymphocyte count was significantly higher among HIV-seronegative women (mean=770 cells/mm(3), standard deviation (SD)=232 cells/mm(3)) than HIV-seropositive women (mean=422cells/mm(3), SD=205 cells/mm(3)). Most HIV-seropositive women were asymptomatic, in WHO clinical stage 1 (84.3%), Among HIV-seropositive women, total white blood count (WBC) and erythrocyte sedimentation rate (ESR) remained significantly correlated with CD4+ after adjusting for other predictors in multivariate analyses, For women of average age 25 years, the CD4+ lymphocyte count increased by about 16 cells/mm(3) for each increment of 1000 WBC cells/mm(3), while each PO mm/hr increase in ESR was associated with a reduction of CD4+ lymphocyte count of about 8 cells/mm(3). Conclusion: These results show that simple and inexpensive haematological indices cannot be recommended for use as alternative measures of HIV-related immunosuppression in this population of mainly asymptomatic women.

Description

Other Available Sources

Research Data

Keywords

Terms of Use

Metadata Only

Endorsement

Review

Supplemented By

Related Stories